T1	Pharmacological_substance 19 30	propafenone
N1000 	Reference T1 MeSH:D011405	propafenone
T2	Pharmacological_substance 76 86	citalopram
N1001 	Reference T2 MeSH:D015283	citalopram
T3	Pharmacological_substance 88 99	Propafenone
N1002 	Reference T3 MeSH:D011405	Propafenone
T4	Pharmacological_substance 103 126	class IC antiarrhythmic
T5	Pharmacological_substance 132 142	citalopram
N1003 	Reference T5 MeSH:D015283	citalopram
T6	Pharmacological_substance 146 184	selective serotonin reuptake inhibitor
N1004 	Reference T6 MeSH:D017367	selective serotonin reuptake inhibitor
T7	Pharmacological_substance 186 190	SSRI
N1005 	Reference T7 MeSH:D017367	SSRI
N1006 	Reference T7 MeSH:D017367	SSRI
T8	Pharmacological_substance 269 280	propafenone
N1007 	Reference T8 MeSH:D011405	propafenone
T9	Pharmacological_substance 285 290	SSRIs
N1008 	Reference T9 MeSH:D017367	SSRIs
T10	Pharmacological_substance 380 391	propafenone
N1009 	Reference T10 MeSH:D011405	propafenone
T11	Pharmacological_substance 396 406	citalopram
N1010 	Reference T11 MeSH:D015283	citalopram
T12	Pharmacological_substance 491 502	propafenone
N1011 	Reference T12 MeSH:D011405	propafenone
T13	Pharmacological_substance 507 517	citalopram
N1012 	Reference T13 MeSH:D015283	citalopram
T15	Disorder 639 664	mild cognitive impairment
N1 	Reference T15 UMLS:C1270972	mild cognitive impairment
T16	Pharmacological_substance 682 693	propafenone
N1013 	Reference T16 MeSH:D011405	propafenone
T18	Disorder 721 751	paroxysmal atrial fibrillation
N2 	Reference T18 UMLS:C0235480	paroxysmal atrial fibrillation
T19	Pharmacological_substance 805 815	citalopram
N1014 	Reference T19 MeSH:D015283	citalopram
T20	Disorder 865 874	dizziness
N3 	Reference T20 UMLS:C0012833	dizziness
T21	Pharmacological_substance 1069 1079	amlodipine
N1015 	Reference T21 MeSH:D017311	amlodipine
T23	Pharmacological_substance 1108 1121	nitroglycerin
N1016 	Reference T23 MeSH:D005996	nitroglycerin
T25	Pharmacological_substance 1144 1152	warfarin
N1017 	Reference T25 MeSH:D014859	warfarin
T27	Pharmacological_substance 1223 1233	Amlodipine
N1018 	Reference T27 MeSH:D017311	Amlodipine
T28	Pharmacological_substance 1242 1255	nitroglycerin
N1019 	Reference T28 MeSH:D005996	nitroglycerin
T29	Pharmacological_substance 1284 1295	propafenone
N1020 	Reference T29 MeSH:D011405	propafenone
T31	Pharmacological_substance 1319 1329	citalopram
N1021 	Reference T31 MeSH:D015283	citalopram
T33	Pharmacological_substance 1588 1599	propafenone
N1022 	Reference T33 MeSH:D011405	propafenone
T34	Pharmacological_substance 1604 1614	citalopram
N1023 	Reference T34 MeSH:D015283	citalopram
T36	Disorder 1662 1671	dizziness
N4 	Reference T36 UMLS:C0012833	dizziness
T37	Disorder 1693 1716	coronary artery disease
N5 	Reference T37 UMLS:C1956346	coronary artery disease
T17	Subject 212 226	older patients
T32	Speculation_cue 239 248	potential
T39	Speculation_cue 333 353	no published reports
T42	Disorder 544 571	propafenone adverse effects
T43	Speculation_cue 451 460	potential
T44	Subject 573 600	An 80-year-old white female
T46	Coreferring_mention 817 820	she
T47	Disorder 845 860	chest tightness
N6 	Reference T47 UMLS:C0232292	chest tightness
T49	Disorder 1014 1034	acute coronary event
T50	Coreferring_mention 1050 1053	She
T52	Disorder 1212 1221	delirious
N7 	Reference T52 UMLS:C0011206	delirious
T55	Speculation_cue 1559 1567	possible
T56	Disorder 1673 1678	falls
N8 	Reference T56 UMLS:C0000921	falls
T57	Disorder 951 956	falls
N9 	Reference T57 UMLS:C0000921	falls
T35	Disorder 1187 1191	fall
N10 	Reference T35 UMLS:C0085639	fall
T53	Disorder 1629 1656	propafenone adverse effects
T22	Combination 55 59	with
T14	Combination 1140 1143	and
